woman in white scrub suit holding gray laptop computer

Transforming bladder cancer diagnosis

A simple urine test, more accurate and non-invasive.

Non-invasive
“Just a urine sample — no pain.”

High accuracy
“Over 90% sensitivity and specificity.”

Sustainable cost
“33% more affordable than the competition.”

Danae UroGeomics

Danae Urogenomics is a leading company in bladder cancer diagnostics. Our state-of-the-art diagnostic systems allow us to offer high-quality services for the detection and monitoring of this disease. We collaborate with scientific institutions and hospitals to continuously improve our diagnostic and prognostic methods. Our scientific partnerships and institutional collaborations ensure the accuracy and effectiveness of our diagnostics.

At Danae Urogenomics, we offer innovative and non-invasive urine-based diagnostic solutions for bladder cancer, enhancing diagnostic accuracy and supporting personalized therapeutic decisions. Our mission is to contribute to a more efficient, less invasive, and patient-centered medicine through the implementation of cutting-edge technology.

Mission

Vision

To become global leaders in the detection and management of bladder cancer, setting new standards in non-invasive diagnostics and personalized care. We aspire to transform the clinical approach to cancer worldwide through precision technology-based solutions that improve therapeutic outcomes and patients' quality of life.